Kyntra Bio (KYNB) Receivables (2014 - 2026)
Kyntra Bio (KYNB) recorded Receivables of $347,000 in Q2 2026, up 155.1% from $136,000 a year earlier but down 96.2% from the prior quarter.
Powered by 
Analysis
Kyntra Bio (KYNB) Receivables (2014 - 2026) Analysis & Trends
At the end of FY2025, Kyntra Bio reported Receivables of $5.5 million, down 81.0% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of -34.6% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $28.98 million in FY2024 (-13.8%), $33.62 million in FY2023 (+18.4%), $28.39 million in FY2022 (+0.2%) and $28.33 million in FY2021 (-38.4%).
- Quarterly Receivables has ranged from $136,000 in Q2 2025 to $82.64 million in Q1 2022 over the past five years.
- On a year-over-year basis, Receivables rose in three of the last seven quarters, with growth averaging 6.4%.
- Peak year-over-year performance for Receivables in the last five years was growth of 217.7% in Q4 2024, against a decline of 99.8% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.04 million (Q1 2026), $216,000 (Q4 2025) and $5.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Kyntra Bio | 21.25 Mn | -386.69 Mn | 1.47 Mn | 347,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 347,000.00 |
| Mar 31, 2026 | 9.04 Mn |
| Dec 31, 2025 | 216,000.00 |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 136,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 28.98 Mn |
| Sep 30, 2024 | 57.53 Mn |
| Jun 30, 2024 | 34.91 Mn |
| Mar 31, 2024 | 65.58 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | 35.69 Mn |
| Jun 30, 2023 | 45.55 Mn |
| Mar 31, 2023 | 29.22 Mn |
| Dec 31, 2022 | 28.39 Mn |
| Sep 30, 2022 | 29.67 Mn |
| Jun 30, 2022 | 60.35 Mn |
| Mar 31, 2022 | 82.64 Mn |
| Dec 31, 2021 | 28.33 Mn |
| Sep 30, 2021 | 59.12 Mn |
API Access
Kyntra Bio Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=KYNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();